Found 8 matching trials
A Crossover Study to Evaluate the Bioavailability of Ibrutinib Suspension and Sprinkle Formulations Compared to Capsules in Healthy Adults PHASE1 The purpose of this study is to assess the relative bioavailability (the ex...
Show More Location
Multiple Locations
Learn More & Join Trial
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) N/A The goal of this observational study is to comprehensively profile six immu...
Show More Location
Radboud University Medical Center
Learn More & Join Trial
LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma EARLY_PHASE1 The purpose of this study is to test the effects of a drug called Voraxaze ...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765 PHASE1 The purpose of this study is to compare the effect of food and two modified...
Show More Location
Multiple Locations
Learn More & Join Trial
Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma PHASE2 This phase II trial studies how well ibrutinib and brentuximab vedotin work...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma PHASE1 The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Show More Location
University of Arizona Cancer Center, Tucson
Learn More & Join Trial
Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL) PHASE1 This is a Phase 1/2, multicenter, open-label study to evaluate the efficacy...
Show More Location
University of Arizona
Learn More & Join Trial
A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001) PHASE1 This study aims to evaluate the safety, tolerability, pharmacodynamic, and ...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital ( Site 0140)
Learn More & Join Trial